跳至主要内容
临床试验/NCT04943354
NCT04943354已完成不适用

Associations of Combinations of Single-nucleotide Polymorphisms and Behavioural Risk Factors With Non-communicable Diseases and Adverse Outcomes in Women With Premature Ovarian Failure

Ryazan State Medical University2 个研究点 分布在 2 个国家目标入组 238 人开始时间: 2020年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
238
试验地点
2
主要终点
Age (years)

研究概览

简要总结

Research objective.

  • To study the associations between combinations of single nucleotide polymorphisms and behavioural risk factors with non-communicable diseases and adverse outcomes in women with premature ovarian failure.

Research objectives:

  • To study the associations between combinations of single-nucleotide polymorphisms and behavioural risk factors with heart rate disorders and adverse outcomes in women with premature ovarian failure
  • Examine the associations between combinations of single nucleotide polymorphisms and behavioural risk factors with stable STIs in women with premature ovarian failure.
  • Examine the associations between combinations of single nucleotide polymorphisms and behavioural risk factors with thrombomolia in women with premature ovarian failure
  • Study the associations between combinations of single nucleotide polymorphisms and behavioural risk factors and adverse cardiovascular outcomes in women with premature ovarian failure.

详细描述

Methods of research:

  • Questionnaire .
  • Clinical examination
  • Blood levels of sex hormones
  • Blood lipid spectrum
  • Coagulogram
  • Glycemic profile
  • EchoCG
  • SMAD
  • ECG
  • Daily ECG monitoring
  • Questionnaire EQ-5D
  • Single-nucleotide polymorphisms of genes of the reninangyotensin-aldosterone system group (AGT, ACE), endothelial dysfunction (NOS3, EDN1), thrombosis-associated (ITGB3, ITGA2, FGB, GPIBA, SERPINE PAI1), pro-inflammatory (CRP, IL17A, IL2, IL10 1, IL10 2, TNFα, CRP 4, IL6, TLR2, TLR3, TLR4, TLR6, TLR9) polymorphisms.

Subject of study.

Women under 45 with Premature Ovarian Failure (PED). It is planned to include 615 people in the study. The study will have both prospective and retrospective parts. Patients will be divided into 4 groups:

  • Women with OED without cardiovascular disease
  • Women with OAI who have cardiovascular disease
  • Control group No 1 Women with normal ovarian function without cardiovascular disease.
  • Control group 2 Women with normal ovarian function without cardiovascular disease.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
— 至 45 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • women under 45 years old
  • presence of premature ovarian insufficiency in the medical history

排除标准

  • male gender
  • age over 45 years

结局指标

主要结局

Age (years)

时间窗: 2 year

Patient age in years

次要结局

  • Menarche (years)(2 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验